SG149854A1 - Amine salt of carbostyril derivative - Google Patents

Amine salt of carbostyril derivative

Info

Publication number: SG149854A1
Authority: SG; Singapore
Prior art keywords: amine salt; carbostyril derivative; carbostyril; derivative; amine
Prior art date: 2004-01-21

Application number

SG200900369-0A

Other languages

English (en)

Inventor

Yoshihiro Nishioka

Shinji Aki

Shigekazu Fujita

Yoshinao Onishi

Shun-Ichiro Sumida

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-21

Filing date

2005-01-20

Publication date

2009-02-27

2005-01-20 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2009-02-27 Publication of SG149854A1 publication Critical patent/SG149854A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Immunology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Quinoline Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SG200900369-0A 2004-01-21 2005-01-20 Amine salt of carbostyril derivative SG149854A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2004013402		2004-01-21

Publications (1)

Publication Number	Publication Date
SG149854A1 true SG149854A1 (en)	2009-02-27

Family

ID=34805383

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200900369-0A SG149854A1 (en)	2004-01-21	2005-01-20	Amine salt of carbostyril derivative

Country Status (22)

Country	Link
US (2)	US7732611B2 (es)
EP (2)	EP1706383B1 (es)
JP (1)	JP4516962B2 (es)
KR (1)	KR100844762B1 (es)
CN (1)	CN1934086B (es)
AR (1)	AR047438A1 (es)
AT (1)	ATE549318T1 (es)
AU (1)	AU2005206430B2 (es)
BR (1)	BRPI0506982A (es)
CA (1)	CA2553231C (es)
CY (2)	CY1112723T1 (es)
DK (2)	DK2253619T3 (es)
ES (2)	ES2544327T3 (es)
HU (1)	HUE027990T2 (es)
MY (1)	MY148416A (es)
PL (2)	PL2253619T3 (es)
PT (2)	PT1706383E (es)
RU (1)	RU2372336C2 (es)
SG (1)	SG149854A1 (es)
SI (2)	SI2253619T1 (es)
TW (1)	TWI340650B (es)
WO (1)	WO2005070892A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6187197B1 (en) *	1998-10-28	2001-02-13	Marvin Haddock	Multi-stage engine coolant recycling process
TWI340650B (en) *	2004-01-21	2011-04-21	Otsuka Pharma Co Ltd	Amine saly of carbostyril derivative
WO2009022674A1 (en) *	2007-08-10	2009-02-19	Otsuka Pharmaceutical Co., Ltd.	Medical composition containing rebamipide
US9486418B2 (en) *	2008-04-08	2016-11-08	Dynamis Pharmaceuticals, Inc.	Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes
SI2285413T1 (sl) *	2008-06-19	2012-09-28	Otsuka Pharma Co Ltd	Farmacevtski sestavek
US9248196B2 (en)	2011-02-25	2016-02-02	Nuformix Limited	Rebamipide complexes and cocrystals

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS517614Y2 (es)	1971-02-12	1976-03-01
US4578381A (en) *	1982-07-05	1986-03-25	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives
JPS597168A (ja)	1982-07-05	1984-01-14	Otsuka Pharmaceut Co Ltd	カルボスチリル誘導体
EP0543018B1 (en) *	1991-06-07	1996-01-10	Otsuka Pharmaceutical Co., Ltd.	Antidiabetic agent
TW227558B (es) *	1992-05-14	1994-08-01	Otsuka Pharma Co Ltd
US5415872A (en)	1992-06-22	1995-05-16	Digestive Care Inc.	Compositions of gastric acid-resistant microspheres containing salts of bile acids
JP2872546B2 (ja) *	1992-11-26	1999-03-17	大塚製薬株式会社	腸粘膜障害保護剤
ATE184793T1 (de) *	1993-10-21	1999-10-15	Otsuka Pharma Co Ltd	Die verwendung von carbostyrilderivaten zur herstellung eines arzneimittels zur hemmung der produktion von interleukin-8
AU8003194A (en)	1993-11-05	1995-05-23	Otsuka Pharmaceutical Co., Ltd.	Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers
JP3621463B2 (ja)	1995-04-26	2005-02-16	大塚製薬株式会社	カルボスチリル誘導体ビスマス塩
AR004214A1 (es) *	1995-10-12	1998-11-04	Otsuka Pharma Co Ltd	Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
GB9613455D0 (en)	1996-06-27	1996-08-28	Aston Molecules Ltd	Analogues or derivatives of quercetin
TW200304813A (en)	2002-03-11	2003-10-16	Novartis Ag	Salts of organic acid
KR20040104020A (ko)	2003-06-02	2004-12-10	진양제약주식회사	신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제
TWI340650B (en) *	2004-01-21	2011-04-21	Otsuka Pharma Co Ltd	Amine saly of carbostyril derivative
JP4719917B2 (ja)	2007-03-30	2011-07-06	国立大学法人岡山大学	アズキ加工食品のアズキ原料品種判定方法

2005
- 2005-01-18 TW TW094101386A patent/TWI340650B/zh not_active IP Right Cessation
- 2005-01-19 MY MYPI20050200A patent/MY148416A/en unknown
- 2005-01-20 PL PL10174397T patent/PL2253619T3/pl unknown
- 2005-01-20 RU RU2006129945/04A patent/RU2372336C2/ru not_active IP Right Cessation
- 2005-01-20 PT PT57041444T patent/PT1706383E/pt unknown
- 2005-01-20 DK DK10174397.9T patent/DK2253619T3/da active
- 2005-01-20 EP EP05704144.4A patent/EP1706383B1/en not_active Expired - Lifetime
- 2005-01-20 SI SI200531494T patent/SI2253619T1/sl unknown
- 2005-01-20 PL PL05704144T patent/PL1706383T3/pl unknown
- 2005-01-20 US US10/586,453 patent/US7732611B2/en not_active Expired - Fee Related
- 2005-01-20 PT PT10174397T patent/PT2253619E/pt unknown
- 2005-01-20 AU AU2005206430A patent/AU2005206430B2/en not_active Ceased
- 2005-01-20 HU HUE05704144A patent/HUE027990T2/en unknown
- 2005-01-20 DK DK05704144.4T patent/DK1706383T3/en active
- 2005-01-20 SI SI200531992T patent/SI1706383T1/sl unknown
- 2005-01-20 CA CA2553231A patent/CA2553231C/en not_active Expired - Fee Related
- 2005-01-20 BR BRPI0506982-3A patent/BRPI0506982A/pt not_active IP Right Cessation
- 2005-01-20 KR KR1020067016600A patent/KR100844762B1/ko not_active Expired - Fee Related
- 2005-01-20 JP JP2006520510A patent/JP4516962B2/ja not_active Expired - Lifetime
- 2005-01-20 EP EP10174397A patent/EP2253619B1/en not_active Expired - Lifetime
- 2005-01-20 CN CN2005800086478A patent/CN1934086B/zh not_active Expired - Fee Related
- 2005-01-20 WO PCT/JP2005/001034 patent/WO2005070892A1/en not_active Ceased
- 2005-01-20 SG SG200900369-0A patent/SG149854A1/en unknown
- 2005-01-20 ES ES05704144.4T patent/ES2544327T3/es not_active Expired - Lifetime
- 2005-01-20 AT AT10174397T patent/ATE549318T1/de active
- 2005-01-20 ES ES10174397T patent/ES2382133T3/es not_active Expired - Lifetime
- 2005-01-20 AR ARP050100199A patent/AR047438A1/es not_active Application Discontinuation
2010
- 2010-04-26 US US12/662,610 patent/US8222276B2/en not_active Expired - Fee Related
2012
- 2012-05-11 CY CY20121100442T patent/CY1112723T1/el unknown
2015
- 2015-10-06 CY CY20151100891T patent/CY1116773T1/el unknown

Also Published As

Publication number	Publication date
AU2005206430A1 (en)	2005-08-04
JP2007514641A (ja)	2007-06-07
TW200529873A (en)	2005-09-16
RU2006129945A (ru)	2008-02-27
HUE027990T2 (en)	2016-11-28
HK1148527A1 (en)	2011-09-09
BRPI0506982A (pt)	2007-07-03
JP4516962B2 (ja)	2010-08-04
DK1706383T3 (en)	2015-08-03
WO2005070892A1 (en)	2005-08-04
HK1101327A1 (en)	2007-10-12
US20070155787A1 (en)	2007-07-05
PT2253619E (pt)	2012-03-29
CA2553231C (en)	2012-03-13
MY148416A (en)	2013-04-30
EP1706383A1 (en)	2006-10-04
EP1706383B1 (en)	2015-07-22
EP2253619A1 (en)	2010-11-24
CY1112723T1 (el)	2016-02-10
KR20060123566A (ko)	2006-12-01
CN1934086A (zh)	2007-03-21
US7732611B2 (en)	2010-06-08
ATE549318T1 (de)	2012-03-15
ES2544327T3 (es)	2015-08-28
PL1706383T3 (pl)	2015-12-31
SI2253619T1 (sl)	2012-04-30
CY1116773T1 (el)	2017-03-15
AU2005206430B2 (en)	2008-12-11
DK2253619T3 (da)	2012-04-16
SI1706383T1 (sl)	2015-09-30
US8222276B2 (en)	2012-07-17
TWI340650B (en)	2011-04-21
ES2382133T3 (es)	2012-06-05
RU2372336C2 (ru)	2009-11-10
AR047438A1 (es)	2006-01-18
KR100844762B1 (ko)	2008-07-07
PT1706383E (pt)	2015-10-15
PL2253619T3 (pl)	2012-08-31
CA2553231A1 (en)	2005-08-04
US20100210684A1 (en)	2010-08-19
CN1934086B (zh)	2013-01-02
EP2253619B1 (en)	2012-03-14

Publication	Publication Date	Title
SG141459A1 (en)	2008-04-28	Novel quinoline derivatives
ZA200610593B (en)	2009-09-30	Diphenylimidazopyrimidine and -imidazole amines as inhibitors of ß-secretase
SG147409A1 (en)	2008-11-28	Amide derivatives
TW200640924A (en)	2006-12-01	VEGF-R2 inhibitors and methods
EP1848430A4 (en)	2011-12-28	NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS
IN2014CN03629A (es)	2015-09-04
SG149891A1 (en)	2009-02-27	Indazole derivatives as inhibitors of hormone-sensitive lipases
SI1761520T1 (sl)	2008-10-31	Inhibitorji kinaze
IL184303A0 (en)	2007-10-31	Amino-pyridines as inhibitors of ??-secretase
IL190292A0 (en)	2009-09-22	PYRIDOPYRIMIDINONE INHIBITORS OF P13Ka
EP1756092A4 (en)	2009-12-02	NEW INHIBITORS OF RHO-KINASEN
DE602004017623D1 (de)	2008-12-18	N-substituierte pyrazolyl-amidyl-benzimidazolyl-c-kit-inhibitoren
SI1828167T1 (sl)	2014-12-31	Akrilamidni derivati kot anitibiotična sredstva
AP2006003705A0 (en)	2006-08-31	Quinoline derivatives for use as mycobacterial inhibitors
IL181897A0 (en)	2007-07-04	Cyclic amine derivative or salt thereof
PL1912647T3 (pl)	2014-02-28	Pochodne chinoliny jako środki antybakteryjne
AP2008004444A0 (en)	2008-04-30	New anti-malaria derivatives of 4-aminoquinoline
TW200613308A (en)	2006-05-01	Cyclobutanetetracarboxylate compound and preparation method thereof
HRP20150163T1 (xx)	2015-03-27	Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina
SG149831A1 (en)	2009-02-27	Benzimidazole derivatives
MY143516A (en)	2011-05-31	Kinase inhibitors
GB0422439D0 (en)	2004-11-10	Inhibitors of infection
SG149854A1 (en)	2009-02-27	Amine salt of carbostyril derivative
SG142306A1 (en)	2008-05-28	Methods for neuroprotection
EP1632476A4 (en)	2007-05-16	ACIDIC ACID SALT OF A CARBAZUCKERAMINE DERIVATIVE